|
ChemMatrix®, a major advance in solid phase peptide synthesis that opens new possibilities for therapeutic peptide developers.
Long, Complex, or Hydrophobic Peptides
While the pharmaceutical industry is discovering the next generation of therapeutic peptide drugs, PCAS BioMatrix has developed a unique expertise and technology to support the life science community to speed up developments and bring complex peptide drug candidates to market.
|



